|
1
|
Xu LP, Wu DP, Han MZ, Huang H, Liu QF, Liu
DH, Sun ZM, Xia LH, Chen J, Wang HX, et al: A review of
hematopoietic cell transplantation in China: Data and trends during
2008–2016. Bone Marrow Transplant. Apr 24–2017.(Epub ahead of
print). View Article : Google Scholar
|
|
2
|
National Cancer Institute (US), . Chronic
myelogenous leukemia treatment: (PDQ(R)): Health professional
versionPDQ Cancer Information Summaries. Bethesda, MD: 2002
|
|
3
|
Vrontaki E, Melagraki G, Voskou S,
Phylactides MS, Mavromoustakos T, Kleanthous M and Afantitis A:
Development of a predictive pharmacophore model and a 3D-QSAR study
for an in silico screening of new potent Bcr-Abl kinase inhibitors.
Mini Rev Med Chem. 17:188–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Webb KC, Harasimowicz M, Janeczek M,
Speiser J, Swan J and Tung R: Development of asymmetric facial
depigmentation in a patient treated with dasatinib with new-onset
hypovitaminosis D: Case report and review of the literature. Case
Rep Dermatol Med. 2017:93590862017.PubMed/NCBI
|
|
5
|
Antoszewska-Smith J, Pawlowska E and
Blasiak J: Reactive oxygen species in BCR-ABL1-expressing cells -
relevance to chronic myeloid leukemia. Acta Biochim Pol. 64:1–10.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saponaro C, Maffia M, Di Renzo N and
Coluccia AM: Is going for cure in CML targeting aberrant glycogen
synthase kinase 3β? Curr Drug Targets. 18:396–404. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haguet H, Douxfils J, Mullier F, Chatelain
C, Graux C and Dogné JM: Risk of arterial and venous occlusive
events in chronic myeloid leukemia patients treated with new
generation BCR-ABL tyrosine kinase inhibitors: A systematic review
and meta-analysis. Expert Opin Drug Saf. 16:5–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang WW, Yang JS, Lin CF, Ho WJ and Lee
MR: Pycnogenol induces differentiation and apoptosis in human
promyeloid leukemia HL-60 cells. Leuk Res. 29:685–692. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saleh M, Shamsasanjan K, Movassaghpour AA,
Akbarzadehlaleh P and Molaeipour Z: Inhibitory effect of
mesenchymal stem cell co-culture on erythroid differentiation of
K562 cells compared to the control croup. Cell J. 19:127–136.
2017.PubMed/NCBI
|
|
10
|
Zhu Y, Wang D, Wang F, Li T, Dong L, Liu
H, Ma Y, Jiang F, Yin H, Yan W, et al: A comprehensive analysis of
GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator
of erythropoiesis. Nucleic Acids Res. 41:4129–4143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nishimura S, Takahashi S, Kuroha T, Suwabe
N, Nagasawa T, Trainor C and Yamamoto M: A GATA box in the GATA-1
gene hematopoietic enhancer is a critical element in the network of
GATA factors and sites that regulate this gene. Mol Cell Biol.
20:713–723. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Raich N and Romeo PH: Erythroid regulatory
elements. Stem Cells. 11:95–104. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gourdon G, Morlé F, Roche J, Tourneur N,
Joulain V and Godet J: Identification of GATA-1 and NF-E2 binding
sites in the flanking regions of the human alpha-globin genes. Acta
Haematol. 87:136–144. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ayala RM, Martínez-López J, Albízua E,
Diez A and Gilsanz F: Clinical significance of Gata-1, Gata-2,
EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol.
84:79–86. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jordan CT and Van Zant G: Recent progress
in identifying genes regulating hematopoietic stem cell function
and fate. Curr Opin Cell Biol. 10:716–720. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Honeycutt KA and Roop DR: c-Myc and
epidermal stem cell fate determination. J Dermatol. 31:368–375.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Nigris F, Sica V, Herrmann J,
Condorelli G, Chade AR, Tajana G, Lerman A, Lerman LO and Napoli C:
c-Myc oncoprotein: Cell cycle-related events and new therapeutic
challenges in cancer and cardiovascular diseases. Cell Cycle.
2:325–328. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pan XN, Chen JJ, Wang LX, Xiao RZ, Liu LL,
Fang ZG, Liu Q, Long ZJ and Lin DJ: Inhibition of c-Myc overcomes
cytotoxic drug resistance in acute myeloid leukemia cells by
promoting differentiation. PLoS One. 9:e1053812014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Y, Yang Y, Meng W, Li Y, Jia Y and Liu
T: Study on the differentiation of K562 cell-line induced by
Tanshinone II A. Hua Xi Yi Ke Da Xue Xue Bao. 33:80–83. 2002.(In
Chinese). PubMed/NCBI
|
|
20
|
Yang Y and Yang M: Effects of C-myc
antisense transcripts on differentiation of k562 cells. Int J
Oncol. 6:419–424. 1995.PubMed/NCBI
|
|
21
|
Sasaki D, Kosunago S, Mikami T, Matsumoto
T and Suzuki M: Growth-inhibition by hemin in K562 human leukemic
cells is related to hemoglobin-producing activity. Biol Pharm Bull.
17:586–590. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu N, Li P, Zang S, Liu Q, Ma D, Sun X
and Ji C: Novel agent nitidine chloride induces erythroid
differentiation and apoptosis in CML cells through c-Myc-miRNAs
axis. PLoS One. 10:e01168802015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gómez-Casares MT, García-Alegria E,
López-Jorge CE, Ferrándiz N, Blanco R, Alvarez S, Vaqué JP,
Bretones G, Caraballo JM, Sánchez-Bailón P, et al: MYC antagonizes
the differentiation induced by imatinib in chronic myeloid leukemia
cells through downregulation of p27(KIP1). Oncogene. 32:2239–2246.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawano T, Horiguchi-Yamada J, Saito S,
Iwase S, Furukawa Y, Kano Y and Yamada H: Ectopic cyclin D1
expression blocks STI571-induced erythroid differentiation of K562
cells. Leuk Res. 28:623–629. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang CH, Lee CY, Lu CC, Tsai FJ, Hsu YM,
Tsao JW, Juan YN, Chiu HY, Yang JS and Wang CC: Resveratrol-induced
autophagy and apoptosis in cisplatin-resistant human oral cancer
CAR cells: A key role of AMPK and Akt/mTOR signaling. Int J Oncol.
50:873–882. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao YR, Lu CC, Lai KC, Yang JS, Kuo SC,
Wen YF, Fushiya S and Wu TS: The novel carboxamide analog ITR-284
induces caspase-dependent apoptotic cell death in human
hepatocellular and colorectal cancer cells. Mol Med Rep.
7:1539–1544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wen YF, Yang JS, Kuo SC, Hwang CS, Chung
JG, Wu HC, Huang WW, Jhan JH, Lin CM and Chen HJ: Investigation of
anti-leukemia molecular mechanism of ITR-284, a carboxamide analog,
in leukemia cells and its effects in WEHI-3 leukemia mice. Biochem
Pharmacol. 79:389–398. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang SM, Yang JS, Tsai SC, Chen MH, Hsu
MH, Lin HY, Chou LC, Chinag JH, Lee KH, Huang LJ, et al: The novel
synthesized
2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3)
compound induces G2/M phase arrest and mitochondrial-dependent
apoptotic cell death through inhibition of CDK1 and AKT activity in
HL-60 human leukemia cells. Int J Oncol. 38:1357–1364. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen HY, Lu HF, Yang JS, Kuo SC, Lo C,
Yang MD, Chiu TH, Chueh FS, Ho HC, Ko YC, et al: The novel
quinolone CHM-1 induces DNA damage and inhibits DNA repair gene
expressions in a human osterogenic sarcoma cell line. Anticancer
Res. 30:4187–4192. 2010.PubMed/NCBI
|
|
30
|
Liu CY, Yang JS, Huang SM, Chiang JH, Chen
MH, Huang LJ, Ha HY, Fushiya S and Kuo SC: Smh-3 induces G(2)/M
arrest and apoptosis through calcium-mediated endoplasmic reticulum
stress and mitochondrial signaling in human hepatocellular
carcinoma Hep3B cells. Oncol Rep. 29:751–762. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin C, Tsai SC, Tseng MT, Peng SF, Kuo SC,
Lin MW, Hsu YM, Lee MR, Amagaya S, Huang WW, et al: AKT
serine/threonine protein kinase modulates baicalin-triggered
autophagy in human bladder cancer T24 cells. Int J Oncol.
42:993–1000. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song QF, Qu YC, Zheng HB, Zhang GH, Lin HG
and Yang JL: Differentiation of erythroleukemia K562 cells induced
by piperine. Ai Zheng. 27:571–574. 2008.(In Chinese). PubMed/NCBI
|
|
33
|
Gu C, Yang Y, Sompallae R, Xu H, Tompkins
VS, Holman C, Hose D, Goldschmidt H, Tricot G, Zhan F, et al: FOXM1
is a therapeutic target for high-risk multiple myeloma. Leukemia.
30:873–882. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liao CL, Lai KC, Huang AC, Yang JS, Lin
JJ, Wu SH, Wood W Gibson, Lin JG and Chung JG: Gallic acid inhibits
migration and invasion in human osteosarcoma U-2 OS cells through
suppressing the matrix metalloproteinase-2/-9, protein kinase B
(PKB) and PKC signaling pathways. Food Chem Toxicol. 50:1734–1740.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin CF, Yang JS, Lin C, Tsai FJ, Lu CC and
Lee MR: CCY-1a-E2 induces G2/M phase arrest and apoptotic cell
death in HL-60 leukemia cells through cyclin-dependent kinase 1
signaling and the mitochondria-dependent caspase pathway. Oncol
Rep. 36:1633–1639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Deutsch VR and Tomer A: Megakaryocyte
development and platelet production. Br J Haematol. 134:453–466.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hofmann WK, Ottmann OG and Hoelzer D:
Megakaryocytic growth factors: Is there a new approach for
management of thrombocytopenia in patients with malignancies?
Leukemia. 13:14–18. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Katayama N, Itoh R, Kato T, Sugawara T,
Mahmud N, Ohishi K, Masuya M, Aoki M, Minami N, Miyazaki H, et al:
Role for C-MPL and its ligand thrombopoietin in early
hematopoiesis. Leuk Lymphoma. 28:51–56. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chi HT, Ly BT, Kano Y, Tojo A, Watanabe T
and Sato Y: ETV6-NTRK3 as a therapeutic target of small molecule
inhibitor PKC412. Biochem Biophys Res Commun. 429:87–92. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang YC, Shieh HR and Chen YJ:
Midostaurin (PKC412) modulates differentiation and maturation of
human myeloid dendritic cells. Toxicol In Vitro. 24:1705–1710.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Anisimov AG, Volkova TO, Chekmasova AA and
Nemova NN: Phorbol-12-myristate-13-acetate prevents the inhibitory
effect of A23187 on erythroid differentiation of K562 cells induced
by dimethylsulfoxide. Izv Akad Nauk Ser Biol. 142–148. 2002.(In
Russian). PubMed/NCBI
|
|
42
|
Lee CH, Yun HJ, Kang HS and Kim HD:
ERK/MAPK pathway is required for changes of cyclin D1 and B1 during
phorbol 12-myristate 13-acetate-induced differentiation of K562
cells. IUBMB Life. 48:585–591. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yuan FF, Zhang XH, Mi RH, Fan RH, Yin QS
and Wei XD: Effects of As2O3 in combination with TPA on K562 cells.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 22:943–949. 2014.(In Chinese).
PubMed/NCBI
|
|
44
|
Xu W, Wei W, Yu Q, Wu C, Ye C, Wu Y and
Yan H: Arsenic trioxide and bortezomib interact synergistically to
induce apoptosis in chronic myelogenous leukemia cells resistant to
imatinib mesylate through Bcr/Abl-dependent mechanisms. Mol Med
Rep. 10:1519–1524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xiang L, Dong W, Wang R, Wei J, Qiu G, Cen
J, Chen Z, Zheng X, Hu S, Xie X, et al: All-trans retinoic acid
enhances the effect of 5-aza-2′-deoxycytidine on p16INK4a
demethylation, and the two drugs synergistically activate retinoic
acid receptor β gene expression in the human erythroleukemia K562
cell line. Oncol Lett. 8:117–122. 2014.PubMed/NCBI
|
|
46
|
Tang XY, Wang CH and Xiao GF: The effect
of ATRA-induced leukemic cell differentiation on Brd7 gene
expression in leukemia cell lines. Zhongguo Shi Yan Xue Ye Xue Za
Zhi. 18:593–596. 2010.(In Chinese). PubMed/NCBI
|
|
47
|
Sive JI and Göttgens B: Transcriptional
network control of normal and leukaemic haematopoiesis. Exp Cell
Res. 329:255–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ebina W and Rossi DJ: Transcription
factor-mediated reprogramming toward hematopoietic stem cells. EMBO
J. 34:694–709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shimizu R and Yamamoto M: GATA-related
hematologic disorders. Exp Hematol. 44:696–705. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ryningen A, Stapnes C, Paulsen K, Lassalle
P, Gjertsen BT and Bruserud O: In vivo biological effects of ATRA
in the treatment of AML. Expert Opin Investig Drugs. 17:1623–1633.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Catani L, Vianelli N, Amabile M, Pattacini
L, Valdrè L, Fagioli ME, Poli M, Gugliotta L, Moi P, Marini MG, et
al: Nuclear factor-erythroid 2 (NF-E2) expression in normal and
malignant megakaryocytopoiesis. Leukemia. 16:1773–1781. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fierro FA, Taubenberger A, Puech PH,
Ehninger G, Bornhauser M, Muller DJ and Illmer T: BCR/ABL
expression of myeloid progenitors increases beta1-integrin mediated
adhesion to stromal cells. J Mol Biol. 377:1082–1093. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen GQ, Wang LS, Wu YL and Yu Y:
Leukemia, an effective model for chemical biology and target
therapy. Acta Pharmacol Sin. 28:1316–1324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang Z, Zhu P, Zhou Y, Sheng Y, Hong Y,
Xiang D, Qian Z, Mosenson J and Wu WS: A novel slug-containing
negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic
stem cell self-renewal. Leukemia. 31:403–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Green MR, Aya-Bonilla C, Gandhi MK, Lea
RA, Wellwood J, Wood P, Marlton P and Griffiths LR: Integrative
genomic profiling reveals conserved genetic mechanisms for
tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes
Chromosomes Cancer. 50:313–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mencalha AL, Binato R, Ferreira GM, Du
Rocher B and Abdelhay E: Forkhead box M1 (FoxM1) gene is a new
STAT3 transcriptional factor target and is essential for
proliferation, survival and DNA repair of K562 cell line. PLoS One.
7:e481602012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Carrett-Dias M, Almeida LK, Pereira JL,
Almeida DV, Filgueira DM, Marins LF, Votto AP and Trindade GS: Cell
differentiation and the multiple drug resistance phenotype in human
erythroleukemic cells. Leuk Res. 42:13–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Nakamura S, Hirano I, Okinaka K, Takemura
T, Yokota D, Ono T, Shigeno K, Shibata K, Fujisawa S and Ohnishi K:
The FOXM1 transcriptional factor promotes the proliferation of
leukemia cells through modulation of cell cycle progression in
acute myeloid leukemia. Carcinogenesis. 31:2012–2021. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Shin JM, Jeong YJ, Cho HJ, Magae J, Bae YS
and Chang YC: Suppression of c-Myc induces apoptosis via an
AMPK/mTOR-dependent pathway by 4-O-methyl-ascochlorin in leukemia
cells. Apoptosis. 21:657–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shi P, Huang Z and Chen G: Rhein induces
apoptosis and cell cycle arrest in human hepatocellular carcinoma
BEL-7402 cells. Am J Chin Med. 36:805–813. 2008. View Article : Google Scholar : PubMed/NCBI
|
